 | Up a level |
Hillmen, Peter, Brown, Jennifer R., Eichhorst, Barbara F., Lamanna, Nicole 
ORCID: 0000-0003-3331-9491, O'Brien, Susan M., Qiu, Lugui, Salmi, Tommi, Hilger, James, Wu, Kenneth, Cohen, Aileen, Huang, Jane and Tam, Constantine S.
(2020).
ALPINE: zanubrutinib versus ibrutinib in relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma.
Future Oncol., 16 (10).
S. 517 - 524.
LONDON:
FUTURE MEDICINE LTD.
ISSN 1744-8301
Rhodes, Joanna, Sail, Kavita, Yazdy, Maryam, Hill, Brian, Shadman, Mazyar, Tuncer, Hande H., Winter, Allison, Kennard, Kaitlin, Allan, John, Ujjani, Chaitra, Brander, Danielle, Cho, Sang Kyu, Sharmokh, Simon, Jiang, Dingfeng, Nabhan, Chadi, Barr, Paul ORCID: 0000-0002-9733-401X, Brown, Jennifer, Fox, Christopher, Schuh, Anna, Eyre, Toby, Lamanna, Nicole ORCID: 0000-0003-3331-9491, Wierda, William, Skarbnik, Alan, Roeker, Lindsey, Bannerji, Rajat, Evens, Andrew M., Pauff, James M., Schuster, Steven, Follows, George, Cheson, Bruce D., Eichhorst, Barbara and Mato, Anthony
(2020).
Factors impacting treatment selection in treatment-naive patients with CLL: a multicenter study.
Leuk. Lymphoma, 61.
S. 104 - 106.
ABINGDON:
TAYLOR & FRANCIS LTD.
ISSN 1029-2403
Seymour, John F., Kipps, Thomas J., Eichhorst, Barbara, Hillmen, Peter, D'Rozario, James, Assouline, Sarit, Owen, Carolyn, Robak, Tadeusz, de la Serna, Javier, Jaeger, Ulrich, Cartron, Guillaume, Montillo, Marco, Lamanna, Nicole ORCID: 0000-0003-3331-9491, Kim, Su Young, Wu, Jenny, Wang, Jue, Lefebure, Marcus, Boyer, Michelle, Humphrey, Kathryn and Kater, Arnon
(2020).
Time-limited venetoclax-rituximab (VenR) in relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL): first presentation of 4-year data from the MURANO study.
Leuk. Lymphoma, 61.
S. 268 - 271.
ABINGDON:
TAYLOR & FRANCIS LTD.
ISSN 1029-2403
Pagel, John M., Coutre, Steven E., Furman, Richard R., Sharman, Jeff P., Cheson, Bruce D., Hillmen, Peter, Barrientos, Jacqueline C., Zelenetz, Andrew D., Kipps, Thomas J., Flinn, Ian W., Ghia, Paolo, Eradat, Herbert A., Ervin, Thomas, Lamanna, Nicole ORCID: 0000-0003-3331-9491, Coiffier, Bertrand, Pettitt, Andrew, Li, Xiaoming, Jahn, Thomas M., O'Brien, Susan M. and Hallek, Michael J.
(2015).
Second Interim Analysis of a Phase 3 Study Evaluating Idelalisib and Rituximab for Relapsed Chronic Lymphocytic Leukemia.
Clin. Lymphoma Myeloma Leuk., 15.
S. S201 - 2.
DALLAS:
CIG MEDIA GROUP, LP.
ISSN 2152-2669
Ghia, Paolo, O'Brien, Susan Mary, Hillmen, Peter, Furman, Richard R., Coutre, Steven E., Sharman, Jeff Porter, Cheson, Bruce D., Pagel, John M., Barrientos, Jacqueline Claudia, Zelenetz, Andrew David, Kipps, Thomas J., Flinn, Ian, Eradat, Herbert Aaron, Lamanna, Nicole ORCID: 0000-0003-3331-9491, Hallek, Michael J., Coiffier, Bertrand, Pettitt, Andrew, Ye, Wei, Jahn, Thomas Michael and Wagner, Lynne I.
(2014).
Health-related quality of life (HRQL) impact of idelalisib (IDELA) in patients (pts) with relapsed chronic lymphocytic leukemia (CLL): Phase 3 results.
J. Clin. Oncol., 32 (15).
ALEXANDRIA:
AMER SOC CLINICAL ONCOLOGY.
ISSN 1527-7755
Furman, Richard R., Sharman, Jeff P., Coutre, Steven E., Cheson, Bruce D., Pagel, John M., Hillmen, Peter, Barrientos, Jacqueline C., Zelenetz, Andrew D., Kipps, Thomas J., Flinn, Ian ORCID: 0000-0001-6724-290X, Ghia, Paolo ORCID: 0000-0003-3750-7342, Eradat, Herbert, Ervin, Thomas, Lamanna, Nicole ORCID: 0000-0003-3331-9491, Coiffier, Bertrand, Pettitt, Andrew R., Ma, Shuo, Stilgenbauer, Stephan, Cramer, Paula, Aiello, Maria, Johnson, Dave M., Miller, Langdon L., Li, Daniel, Jahn, Thomas M., Dansey, Roger D., Hallek, Michael and O'Brien, Susan M.
(2014).
Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia.
N. Engl. J. Med., 370 (11).
S. 997 - 1008.
WALTHAM:
MASSACHUSETTS MEDICAL SOC.
ISSN 1533-4406
Coutre, Steven E., Furman, Richard R., Sharman, Jeff Porter, Cheson, Bruce D., Pagel, John M., Hillmen, Peter, Barrientos, Jacqueline Claudia, Zelenetz, Andrew David, Kipps, Thomas J., Flinn, Ian, Ghia, Paolo, Eradat, Herbert Aaron, Ervin, Thomas J., Lamanna, Nicole ORCID: 0000-0003-3331-9491, Coiffier, Bertrand, Pettitt, Andrew, Kim, Yeonhee, Jahn, Thomas Michael, O'Brien, Susan Mary and Hallek, Michael J.
(2014).
Second interim analysis of a phase 3 study evaluating idelalisib and rituximab for relapsed CLL.
J. Clin. Oncol., 32 (15).
ALEXANDRIA:
AMER SOC CLINICAL ONCOLOGY.
ISSN 1527-7755
Furman, Richard R., Sharman, Jeff P., Coutre, Steven E., Cheson, Bruce D., Pagel, John M., Hillmen, Peter, Barrientos, Jacqueline C., Zelenetz, Andrew D., Kipps, Thomas J., Flinn, Ian, Ghia, Paolo ORCID: 0000-0003-3750-7342, Eradat, Herbert, Ervin, Thomas, Lamanna, Nicole ORCID: 0000-0003-3331-9491, Hallek, Michael, Coiffier, Bertrand, Pettitt, Andrew R., Ma, Shuo, Stilgenbauer, Stephan, Cramer, Paula, Aiello, Maria, Johnson, Dave M., Miller, Langdon L., Li, Daniel, Jahn, Thomas M., Dansey, Roger D. and O'Brien, Susan M.
(2013).
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Idelalisib and Rituximab for Previously Treated Patients with Chronic Lymphocytic Leukemia (CLL).
Blood, 122 (21).
WASHINGTON:
AMER SOC HEMATOLOGY.
ISSN 1528-0020